H.R.1854 - Prescription Drug Monitoring Act of 2017115th Congress (2017-2018) |
|Sponsor:||Rep. Jenkins, Evan H. [R-WV-3] (Introduced 04/03/2017)|
|Committees:||House - Energy and Commerce; Judiciary|
|Latest Action:||House - 04/24/2017 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.1854 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (04/03/2017)
Prescription Drug Monitoring Act of 2017
This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply.
To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse Grant Program to establish and maintain a data-sharing hub.